Schaeffer's Top Stock Picks for '25

Analyst Upgrades: Tesla Motors, Monsanto, AbbVie

Analysts upwardly revised their ratings and price targets on Tesla Motors Inc (NASDAQ:TSLA), Monsanto Company (NYSE:MON), and AbbVie Inc (NYSE:ABBV)

Jun 8, 2015 at 10:01 AM
facebook X logo linkedin


Analysts are weighing in today on electric automaker Tesla Motors Inc (NASDAQ:TSLA), agricultural concern Monsanto Company (NYSE:MON), and biopharmaceutical firm AbbVie Inc (NYSE:ABBV). Here's a quick roundup of today's bullish brokerage notes on TSLA, MON, and ABBV.

  • TSLA is up 2.6% this morning at $255.70 on reports Panasonic is sending hundreds of employees to the car producer's Gigafactory in Nevada to prepare to make lithium-ion batteries next year. On top of this, Baird raised its price target to $335 from $275, marking a 31% premium to current levels. The shares have been solid on the charts, adding 15% in 2015. Option traders have been betting on more upside, too. Tesla Motors Inc's 10-day International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) call/put volume ratio of 1.35 is higher than three-fourths of comparable readings from the past year. On a separate note, TSLA will hold its annual shareholder meeting tomorrow.

  • MON's second takeover bid for Syngenta AG (ADR) (NYSE:SYT) has been rejected, with the latter company citing regulatory concerns. Regardless, Monsanto Company is up 0.6% on the day at $114.62, as it received an upgrade at Atlantic Equities to "neutral" from "underweight." Analysts are split on the stock. While seven brokerage firms say it's a "strong buy," six others deem it only a "hold." Going by its recent price action, the bearish attention seems more deserving. MON has dropped 9% since touching a 2015 high of $126 on Feb. 25.

  • Thanks to a pair of price-target hikes, ABBV has added 0.6% this morning to hit $67.90. Specifically, Jefferies upped its price target to $90 from $86, while Credit Suisse raised its mark to $72 from $69. The Street already has a decidedly bullish stance on the shares, with 80% of brokerage firms calling them a "strong buy," and not a single "sell" to be found. On the charts, AbbVie Inc has been gaining lately, outpacing the S&P 500 Index (SPX) by almost 15 percentage points over the past three months. 
 
 

Which of These SUB-$5 Stocks Could 26x From Here? (AD)

He called a rare 11x on Tesla…

Then he called a 26x on Workhorse…

Then an even rarer 35x on Nio Inc…

Now Tim Bohen says these 5 tiny “America First” stocks are next up in 2025.

They’re trading for less than $5 right now.

But thanks to Elon & Trump’s new alliance…

They could be off to the races in Trump’s first 100 days.

And right now for a limited time…

You can get the names & tickers for just $1 here. (AD)

10 Stock Picks FREE
 
 

Featured Articles from Trusted Partners:

🚀 One Stock Pick Could Change Everything in 2025
What if one stock pick could define your success next year? Get 10 expert-vetted stocks set for 2025—plus 5 bonus picks to watch now. Get the Report →

🆕 New Options Need New Trading Strategies
Zero-DTE options are the newest (and hottest) options to trade.  Professional traders have rushed into the market and are making a mint.  Don’t get left behind - learn all about these options, how to trade them, market setups to profit from, plus much more. Download now →

👀 Revealed: 3 Defensive Stocks for Your Portfolio
Worried about the market? This free report reveals 3 under-the-radar defensive stocks for uncertain times in any kind of economy.

 

 
 

FREE Report Download

 

Follow us on X, Follow us on Twitter